10 Unstoppable Stocks That Could Double Your Money
Generating significant returns and multiplying their money in the stock market remains a primary goal for most investors.
Novavax Inc (NVAX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 62,983 | $236,901 | 0.2% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.50 | 1,000 | Officer | 14,473 | 2023-03-10 | Filing | |
| $7.04 | 2,000 | Officer | 13,473 | 2023-03-07 | Filing | |
| $7.48 | 3,000 | Officer | 11,473 | 2023-03-06 | Filing | |
| $139.64 | 700 | Director | 2,800 | 2021-05-19 | Filing | |
| $48.83 | 1,500 | Director | 1,500 | 2020-06-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.02 | 4,150 | 14,770 | 2024-12-13 | Filing | ||
| $8.00 | 5,400 | 51,760 | 2024-12-31 | Filing | ||
| $8.48 | 4,600 | 57,160 | 2024-12-24 | Filing | ||
| $14.09 | 7,500 | 61,760 | 2024-06-21 | Filing | ||
| $14.28 | 1,107 | 69,260 | 2024-06-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,674,378 | $100,472,762 | 0% | |
| 2. | 12,967,029 | $83,118,657 | 0% | |
| 3. | 6,880,481 | $44,103,883 | 26.58% | |
| 4. | 19,538 | $17,887,039 | 0.69% | |
| 5. | 1,345,140 | $8,622,347 | 0% |
News See All
11 High-Risk High-Reward Growth Stocks To Buy Now
The stock market has an ever-changing environment, leaving investors constantly looking for opportunities that promise substantial returns for their investments.
Novavax, Inc. (NASDAQ:NVAX) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to Novavax Fourth Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode.
10 Under-the-Radar Stocks with Massive Upside for 2025
Investing in under-the-radar stocks can be a savvy move for those looking to diversify their portfolios and potentially reap significant rewards.
Why Vaccine Stocks, Lucid (LCID) Are Rallying
The Louisiana Department of Health noted yesterday that a 65-year-old hospital patient had died due to bird flu.
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript
Operator: Good morning and welcome to Novavax' Third Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode.
7 Best Under The Radar Stocks to Buy According to Analysts
Billionaire investor and entrepreneur Mark Cuban recently shared his thoughts on the current state of the economy, politics, and the upcoming presidential election.
10 High-Flying Stocks to Buy Now
The equity markets are priced for a soft landing. This means that even the fear of a mild recession might trigger a significant equity-market correction.
Novavax, Inc. (NASDAQ:NVAX) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Novavax' Second Quarter 2024 Financial Results and Operational Highlights Conference Call. All participants will be in a listen-only mode.
Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
Jim Cramer in a latest program discussed the changing consumer trends in the US, wondering whether the consumer is just “fed up” of paying high prices and becoming “frugal.” Cramer said this “...